HAVEN 2 Updated Analysis: Multicenter, Open-Label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Pediatric Patients with Hemophilia A with Inhibitors

被引：0
|
作者：
Young, Guy
Sidonio, Robert F.
Liesner, Ri
Oldenburg, Johannes
Chang, Tiffany
Uguen, Marianne
Dhalluin, Christophe
Schmitt, Christophe
Levy, Gallia G.
Shima, Midori
Mahlangu, Johnny
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
85
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Pharmacokinetics, efficacy and safety of IMMUNATE® Solvent/Detergent (IMMUNATE® S/D) in previously treated patients with severe hemophilia A:: Results of a prospective, multicenter, open-label phase III study
    Nemes, L.
    Lissitchkov, T.
    Dobaczewski, G.
    Klukowska, A.
    Komrska, V.
    Zimmermann, R.
    Auerswald, G.
    Engl, W.
    Abbuehl, B.
    Pavlova, B. G.
    Ehrlich, H. J.
    ACTA HAEMATOLOGICA, 2008, 119 (02) : 89 - 97
  • [32] Pharmacokinetics, Pharmacodynamics, and Safety of Pasireotide LAR in Patients With Acromegaly: A Randomized, Multicenter, Open-Label, Phase I Study
    Petersenn, Stephan
    Bollerslev, Jens
    Arafat, Ayman M.
    Schopohl, Jochen
    Serri, Omar
    Katznelson, Laurence
    Lasher, Janet
    Hughes, Gareth
    Hu, Ke
    Shen, George
    Resendiz, Karina Hermosillo
    Giannone, Vanessa
    Beckers, Albert
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (11): : 1308 - 1317
  • [33] PHASE 3B, OPEN-LABEL, MULTICENTER, CONTINUATION STUDY OF RURIOCTOCOG ALFA PEGOL FOR PROPHYLAXIS IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA A
    Alvarez Roman, M. T.
    Mullins, E.
    Chowdary, P.
    Stasyshyn, O.
    Zhang, J.
    Engl, W.
    Tangada, S.
    HAEMATOLOGICA, 2019, 104 : 112 - 113
  • [34] Safety and efficacy of long-term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: A phase 3b, multicenter, single-arm study (STASEY)
    Jimenez-Yuste, Victor
    Peyvandi, Flora
    Klamroth, Robert
    Castaman, Giancarlo
    Shanmukhaiah, Chandrakala
    Rangarajan, Savita
    Garcia Chavez, Jaime
    Martinez, Raul
    Kenet, Gili
    Alzahrani, Hazaa
    Robson, Susan
    Schmitt, Christophe
    Kiialainen, Anna
    Meier, Oliver
    Ozelo, Margareth
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (08)
  • [35] Efficacy and safety of tolvaptan in patients with malignant ascites: a phase 2, multicenter, open-label, dose-escalation study
    Kudo, Toshihiro
    Murai, Yoshiyuki
    Kojima, Yoshitsugu
    Uehara, Kenji
    Satoh, Taroh
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (03) : 354 - 362
  • [36] An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction
    Cicin, Irfan
    Oukkal, Mohammed
    Mahfouf, Hassen
    Mezlini, Amel
    Larbaoui, Blaha
    Ben Ahmed, Slim
    Errihani, Hassan
    Alsaleh, Khalid
    Belbaraka, Rhizlane
    Yumuk, Perran Fulden
    Goktas, Burce
    Ozguroglu, Mustafa
    EUROPEAN JOURNAL OF BREAST HEALTH, 2022, 18 (01) : 63 - 73
  • [37] Pharmacokinetics, Pharmacodynamics, and Safety of Nivolumab in Patients With Sepsis-Induced Immunosuppression: A Multicenter, Open-Label Phase 1/2 Study
    Watanabe, Eizo
    Nishida, Osamu
    Kakihana, Yasuyuki
    Odani, Motoi
    Okamura, Tatsuaki
    Harada, Tomohiro
    Oda, Shigeto
    SHOCK, 2020, 53 (06): : 686 - 694
  • [38] Clinical Efficacy and Safety of Mesalamine Suppositories in the Treatment of Pediatric Patients with Ulcerative Proctitis: A Multicenter, Open-Label Study
    Heyman, Melvin B.
    Kierkus, Jaroslaw
    Spenard, Jean
    Giguere, Monique
    GASTROENTEROLOGY, 2009, 136 (05) : A671 - A671
  • [39] Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors
    Kempton, Christine
    Trask, Peter
    Parnes, Aric
    Niggli, Markus
    Campinha-Bacote, Avrita
    Callaghan, Michael U.
    O'Connell, Niamh
    Paz-Priel, Ido
    Mahlangu, Johnny N.
    HAEMOPHILIA, 2021, 27 (02) : 221 - 228
  • [40] An Open-Label, Multicenter,Single-Arm, Phase I Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of XNW5004 in Patients with Relapsed or Refractory Hematologic Malignancies
    Zheng Weiwei
    Zhou Hui
    Xi Zhang
    Jing Hongmei
    Zhou Dongmei
    Zhou Fang
    Gao Li
    Wan Wei
    Song Yaobo
    Yan, Haung
    Xu Linfeng
    Hu Yonghan
    Le Meijie
    Qi Junyuan
    Qiu, Lugui
    BLOOD, 2022, 140 : 9353 - 9355
12345